China, Oct. 26 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized, Double-blind Phase I Clinical Trial of SAL0896 Injection'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135079
Registration Time: 2026/10/23
Type: Interventional study
Primary Sponsor: Beijing Jishuitan Hospital, Capital Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348534
Published by HT Digital Content Services with permission from Health Daily Digest....